2-octynoic acid has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Liu, C; Liu, N; Wang, X; Xue, B; Yang, D; Yu, X; Zhu, H | 1 |
1 other study(ies) available for 2-octynoic acid and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
2-octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase.
Topics: AMP-Activated Protein Kinases; Antiviral Agents; Cell Line; Enzyme Activation; Fatty Acids, Monounsaturated; Gene Expression Regulation; Hepacivirus; Hepatitis C; Humans; Interferon Regulatory Factors; Lipid Metabolism; MicroRNAs; Virus Replication | 2013 |